Fosamax Expert Grilled Over Financial Ties To Merck

Law360, New York (April 9, 2012, 6:52 PM EDT) -- A Columbia University medical school professor received at least $150,000 from Merck & Co. before testifying for the drug company in a woman's suit claiming the osteoporosis drug Fosamax caused her jaw deterioration, the plaintiff's lawyer alleged in state court Monday.

Plaintiffs lawyer Timothy O'Brien spent hours during a New Jersey state court trial on Monday questioning Merck expert John Bilezikian, asking him to confirm that he had received between $150,000 and $200,000 from the company over 15 years and whether he helped Merck market its...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.